Transient Protein Expression Market Size and Forecast (2021-2031)
Transient Protein Expression Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
$3,633 – $6,433
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Market Drivers of the Transient Protein Expression Market
Increasing Applications of Protein Expression Systems
Animal and plant cell-based transient protein expression systems have been in use for the last three decades. Significant advancements in proteomics in recent years have resulted in the availability of newer recombinant protein varieties. The practicality and reproducibility of transient protein expression in animal and plant cells encourage research and development activities to extend their applications in human cell lines. Many contract research and development organizations as well as biopharmaceutical companies, among others, have focused their efforts on incorporating transient protein expression into their production processes. This type of expression system allows them to use different genes to create recombinant proteins without relying on the development of stable cell lines.
The temporary protein expression process finds widespread application in the manufacturing of growth factors, cytokines, hormones, blood products, modified human proteins, and monoclonal antibodies. Moreover, the creation and use of effective bioprocessing techniques have become essential for the commercial synthesis of recombinant proteins with significant therapeutic value. Recent developments in the field of bioprocessing are being applied to provide efficient methods for generating recombinant proteins. Modern Quality by Design concepts, continuous upstream processing, continuous chromatography, integrated continuous bioprocessing, high-throughput devices for efficient bioprocess optimization, disposable systems, and process analytics technologies for higher yields of high-quality products are among the recent developments that propel the adoption of transient protein expression systems.
Plant-Based Expression Systems for Therapeutic Protein Production in Emerging Countries to Create Market Opportunities
The use of microbial or mammalian cell-based expression systems has been a common practice in recombinant protein production processes; however, plant-based expression has been promoted as a cost-effective, scalable, safe, and sustainable alternative in recent years. Advancements in transient expression methods have resulted in a significantly shortened duration of protein synthesis and the improved yield of recombinant proteins in plant-based systems. A shift in consumer preference toward plant-based products compels pharmaceutical and biopharmaceutical companies to focus on plant-based synthesis of therapeutic proteins. The use of plants has excellent potential for improving yields of proteins that can be administered for the prevention or treatment of human and animal diseases. The use of therapeutic proteins is likely to surge in the healthcare sector in the coming years due to the ongoing restructuring of regulatory frameworks and growing awareness about transient protein expression in plants. Maximum scale‐up possibility, low growth costs, complex protein production ability, low contamination (especially involving human pathogens) risks, and optimized growth conditions are among the key advantages associated with carrying out transient protein expression in plants. Moreover, plants are considered safer compared to other expression systems as they do not produce endotoxins and cause less harm to humans. Thus, plant-based expression systems for therapeutic protein expression are emerging as vital opportunities for the transient protein expression market growth during the forecast period.
Transient Protein Expression Market: Segmental Overview
Key segments that contributed to the derivation of the transient protein expression market analysis are product type, application, and end user.
• Based on product type, the transient protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The instruments segment held the largest market share in 2023.
• By application, the market is segmented into genomic research, gene therapy, bioproduction, cancer research, and drug development. The genomic research segment accounted for the largest share of the market in 2023.
• Based on end user, the transient protein expression market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment dominated the market in 2023.
Transient Protein Expression Market: Geographical Overview
The geographic scope of the transient protein expression market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. The North America transient protein expression market has been analyzed on the basis of the US, Canada, and Mexico. In terms of revenue, North America accounted for the largest market share in 2023. The US is the world’s most important market for transient protein expression procedures and systems. The market growth in the country is attributed to extensive research and development activities in the biopharmaceuticals industry, a growing number of startups involved in protein expression, and the rising adoption of recombinant protein for therapeutic applications. In addition, the presence of various market leaders operating in the US contributes notably to the expansion of the transient protein expression market size.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to our latest study on “Transient Protein Expression Market Forecast to 2031 – Global Analysis – Product Type, Application, End User, and Geography,” the market was valued at US$ 836.68 million in 2023 and is projected to reach US$ 1,320.38 million by 2031; it is expected to register a CAGR of 5.9% from 2023 to 2031. The report highlights the key factors driving the transient protein expression market growth and prominent players with their developments in the market.
The transient protein expression market has been segmented on the basis of product type, application, and end user.
Based on product type, the transient protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The instruments segment held the largest market share in 2023. Instruments used in transient protein expression are categorized as automated transient protein expression systems and manual transient protein expression systems. The choice of instrument depends on the kind of protein, the requirements for functional activity, and the desired yield. In March 2022, ProteoGenix launched its XtenCHOTM transient expression system. This new proprietary mammalian cell-based expression host is designed to achieve up to 10 times more yields with less hands-on time compared to existing solutions, which can be ascribed to enhanced plasmid stability and optimized metabolism. The new CHO host aims to simplify recombinant protein production and speed up early-phase drug screening. The manual method entirely depends on the abilities and availability of accomplished cell culture scientists and technicians, among others. It is highly repetitive and requires a considerable time investment.
By application, the market is segmented into genomic research, gene therapy, bioproduction, cancer research, and drug development. The genomic research segment accounted for the largest share of the market in 2023. Large-scale transient gene expression (TGE) is a technology that is deemed suitable for producing recombinant therapeutic proteins. TGE involves producing a recombinant protein over 1-14 days following the transfer of DNA into single-cell suspension cultures. A recombinant gene is typically cloned in a nonviral expression vector and then transfected into cells using a chemical delivery agent such as calcium phosphate (CaPi). On the other hand, stable transfection results in high protein yield. After the recombinant DNA is transfected into animal cells, it can either be integrated (stable expression) into the host genome or maintained in episomal form (transient expression). In stable expression systems, the foreign gene is passed on to subsequent generations, and the expression is maintained from one generation to the next. On the other hand, transient expression is also termed as temporary expression as the foreign gene is not passed on to the next generations.
Genomics is the study of all the genes of a person (the genome), including their interactions with each other and with the environment of the individual. Objectives of genomic research include determining the function of genes and other genome elements; identifying differences in human DNA sequencing and their consequences; discovering the structure of 3-dimensional proteins; investigating the function of various protein structures; exploring interactions between DNA and proteins in vivo settings; comparing genome sequences of organisms; developing new technologies to improve genomics research and enhance DNA sequencing performance; and exploring ethical, legal, and social issues related to genomic research.
Based on end user, the transient protein expression market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment dominated the market in 2023. Cancer and infectious diseases are a few of the most common causes of death in the world. Many expression systems have been developed to aid in the production of pharmaceutical products. In recent years, efforts have been made to develop therapeutic proteins directed against infectious diseases and cancer by using plants as bioreactors. Recent advancements in plant-based (stable and transient) therapeutic protein expression along with a shift in focus toward the commercial production of vaccines, antibodies, and biopharmaceuticals leads to maximum use of therapeutic protein expression system in pharmaceutical and biotechnology companies. Besides, pharmaceutical and biotechnology firms are increasing their spending on research and R&D activities. Cell-free protein expression systems have been one of the most recent developments that have the potential to benefit the transient protein expression market over the forecast period.
Thermo Fisher Scientific, Promega Corporation, Merck KGAA, Takara Bio Inc, Qiagen, Bio-Rad Laboratories, Inc., New England Biolabs, Genscript Biotech Corporation, Agilent, Lonza, Mirus Bio LLC, and MaxCyte Inc are among the leading companies operating in the global transient protein expression market.
Companies operating in the transient protein expression market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the transient protein expression market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall transient protein expression market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
A few of the significant developments by key market players are listed below.
• Thermo Fisher Scientific to Acquired QIAGEN N.V. Benefits of the Transaction are Expands Specialty Diagnostics Portfolio with Attractive Molecular Diagnostics Capabilities, Including Infectious Disease Testing, Complementary Offering Enhances Unique Value Proposition for Life Sciences Customers, Commercial and Geographic Reach Expand Customer Access, Delivers Attractive Financial Benefits through the PPI Business System, Including Proven Integration Approach. (Source: Thermo Fisher Scientific Inc., Press Release, March 2020)
• Merck signed agreements licensing its CRISPR technology to two companies PanCELLa, a cell therapy firm, and Takara Bio USA, Inc., a biotechnology company. Licenses aim to accelerate drug discovery research leading to the development of new therapies, PanCELLa agreement marks Merck’s first CRISPR license for bioproduction, Takara Bio USA agreement gives access to Merck’s CRISPR integration and vector technologies for Takara’s vector products and cell engineering services. (Source: Merck, Newsletter, October 2020).
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global transient protein expression market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global market trends and outlook coupled with the factors driving the transient protein expression, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Transient Protein Expression Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Transient Protein Expression Market – Key Market Dynamics
5.1 Transient Protein Expression Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Applications of Protein Expression Systems
5.2.2 Surging Popularity of Precision Medicine
5.3 Market Restraints
5.3.1 High Cost of Products
5.4 Market Opportunities
5.4.1 Plant-Based Expression Systems for Therapeutic Protein Production
5.5 Future Trends
5.5.1 Integration of Artificial Intelligence (AI) and Automation Technologies
5.6 Impact of Drivers and Restraints:
6. Transient Protein Expression Market – Global Market Analysis
6.1 Transient Protein Expression Market Revenue (US$ Million), 2021-2031
6.2 Transient Protein Expression Market Forecast Analysis
7. Transient Protein Expression Market Analysis – by Product Type
7.1 Instruments
7.1.1 Overview
7.1.2 Instruments: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents
7.2.1 Overview
7.2.2 Reagents: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Expression Vectors
7.3.1 Overview
7.3.2 Expression Vectors: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Competent Cells
7.4.1 Overview
7.4.2 Competent Cells: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
8. Transient Protein Expression Market Analysis – by Application
8.1 Genomic Research
8.1.1 Overview
8.1.2 Genomic Research: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Gene Therapy
8.2.1 Overview
8.2.2 Gene Therapy: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Bio production
8.3.1 Overview
8.3.2 Bio production: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Cancer Research
8.4.1 Overview
8.4.2 Cancer Research: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Drug Development
8.5.1 Overview
8.5.2 Drug Development: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9. Transient Protein Expression Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Academic and Research Institutes
9.2.1 Overview
9.2.2 Academic and Research Institutes: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Clinical Research Organizations
9.3.1 Overview
9.3.2 Clinical Research Organizations: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10. Transient Protein Expression Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Transient Protein Expression Market Overview
10.2.2 North America: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Transient Protein Expression Market Breakdown, by Product Type
10.2.3.1 North America: Transient Protein Expression Market – Revenue and Forecast Analysis – by Product Type
10.2.4 North America: Transient Protein Expression Market Breakdown, by Application
10.2.4.1 North America: Transient Protein Expression Market – Revenue and Forecast Analysis – by Application
10.2.5 North America: Transient Protein Expression Market Breakdown, by End User
10.2.5.1 North America: Transient Protein Expression Market – Revenue and Forecast Analysis – by End User
10.2.6 North America: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.2.1 United States: Transient Protein Expression Market Breakdown, by Product Type
10.2.6.2.2 United States: Transient Protein Expression Market Breakdown, by Application
10.2.6.2.3 United States: Transient Protein Expression Market Breakdown, by End User
10.2.6.3 Canada: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.3.1 Canada: Transient Protein Expression Market Breakdown, by Product Type
10.2.6.3.2 Canada: Transient Protein Expression Market Breakdown, by Application
10.2.6.3.3 Canada: Transient Protein Expression Market Breakdown, by End User
10.2.6.4 Mexico: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.4.1 Mexico: Transient Protein Expression Market Breakdown, by Product Type
10.2.6.4.2 Mexico: Transient Protein Expression Market Breakdown, by Application
10.2.6.4.3 Mexico: Transient Protein Expression Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Transient Protein Expression Market Overview
10.3.2 Europe: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Transient Protein Expression Market Breakdown, by Product Type
10.3.3.1 Europe: Transient Protein Expression Market – Revenue and Forecast Analysis – by Product Type
10.3.4 Europe: Transient Protein Expression Market Breakdown, by Application
10.3.4.1 Europe: Transient Protein Expression Market – Revenue and Forecast Analysis – by Application
10.3.5 Europe: Transient Protein Expression Market Breakdown, by End User
10.3.5.1 Europe: Transient Protein Expression Market – Revenue and Forecast Analysis – by End User
10.3.6 Europe: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.3.6.2 Germany: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.2.1 Germany: Transient Protein Expression Market Breakdown, by Product Type
10.3.6.2.2 Germany: Transient Protein Expression Market Breakdown, by Application
10.3.6.2.3 Germany: Transient Protein Expression Market Breakdown, by End User
10.3.6.3 United Kingdom: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.3.1 United Kingdom: Transient Protein Expression Market Breakdown, by Product Type
10.3.6.3.2 United Kingdom: Transient Protein Expression Market Breakdown, by Application
10.3.6.3.3 United Kingdom: Transient Protein Expression Market Breakdown, by End User
10.3.6.4 France: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.4.1 France: Transient Protein Expression Market Breakdown, by Product Type
10.3.6.4.2 France: Transient Protein Expression Market Breakdown, by Application
10.3.6.4.3 France: Transient Protein Expression Market Breakdown, by End User
10.3.6.5 Italy: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.5.1 Italy: Transient Protein Expression Market Breakdown, by Product Type
10.3.6.5.2 Italy: Transient Protein Expression Market Breakdown, by Application
10.3.6.5.3 Italy: Transient Protein Expression Market Breakdown, by End User
10.3.6.6 Spain: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.6.1 Spain: Transient Protein Expression Market Breakdown, by Product Type
10.3.6.6.2 Spain: Transient Protein Expression Market Breakdown, by Application
10.3.6.6.3 Spain: Transient Protein Expression Market Breakdown, by End User
10.3.6.7 Rest of Europe: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.7.1 Rest of Europe: Transient Protein Expression Market Breakdown, by Product Type
10.3.6.7.2 Rest of Europe: Transient Protein Expression Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: Transient Protein Expression Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Transient Protein Expression Market Overview
10.4.2 Asia Pacific: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Transient Protein Expression Market Breakdown, by Product Type
10.4.3.1 Asia Pacific: Transient Protein Expression Market – Revenue and Forecast Analysis – by Product Type
10.4.4 Asia Pacific: Transient Protein Expression Market Breakdown, by Application
10.4.4.1 Asia Pacific: Transient Protein Expression Market – Revenue and Forecast Analysis – by Application
10.4.5 Asia Pacific: Transient Protein Expression Market Breakdown, by End User
10.4.5.1 Asia Pacific: Transient Protein Expression Market – Revenue and Forecast Analysis – by End User
10.4.6 Asia Pacific: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.4.6.1 Asia Pacific: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.4.6.2 China: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.2.1 China: Transient Protein Expression Market Breakdown, by Product Type
10.4.6.2.2 China: Transient Protein Expression Market Breakdown, by Application
10.4.6.2.3 China: Transient Protein Expression Market Breakdown, by End User
10.4.6.3 Japan: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.3.1 Japan: Transient Protein Expression Market Breakdown, by Product Type
10.4.6.3.2 Japan: Transient Protein Expression Market Breakdown, by Application
10.4.6.3.3 Japan: Transient Protein Expression Market Breakdown, by End User
10.4.6.4 India: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.4.1 India: Transient Protein Expression Market Breakdown, by Product Type
10.4.6.4.2 India: Transient Protein Expression Market Breakdown, by Application
10.4.6.4.3 India: Transient Protein Expression Market Breakdown, by End User
10.4.6.5 Australia: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.5.1 Australia: Transient Protein Expression Market Breakdown, by Product Type
10.4.6.5.2 Australia: Transient Protein Expression Market Breakdown, by Application
10.4.6.5.3 Australia: Transient Protein Expression Market Breakdown, by End User
10.4.6.6 South Korea: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.6.1 South Korea: Transient Protein Expression Market Breakdown, by Product Type
10.4.6.6.2 South Korea: Transient Protein Expression Market Breakdown, by Application
10.4.6.6.3 South Korea: Transient Protein Expression Market Breakdown, by End User
10.4.6.7 Rest of APAC: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.7.1 Rest of APAC: Transient Protein Expression Market Breakdown, by Product Type
10.4.6.7.2 Rest of APAC: Transient Protein Expression Market Breakdown, by Application
10.4.6.7.3 Rest of APAC: Transient Protein Expression Market Breakdown, by End User
10.5 South and Central America
10.5.1 South and Central America Transient Protein Expression Market Overview
10.5.2 South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 South and Central America: Transient Protein Expression Market Breakdown, by Product Type
10.5.3.1 South and Central America: Transient Protein Expression Market – Revenue and Forecast Analysis – by Product Type
10.5.4 South and Central America: Transient Protein Expression Market Breakdown, by Application
10.5.4.1 South and Central America: Transient Protein Expression Market – Revenue and Forecast Analysis – by Application
10.5.5 South and Central America: Transient Protein Expression Market Breakdown, by End User
10.5.5.1 South and Central America: Transient Protein Expression Market – Revenue and Forecast Analysis – by End User
10.5.6 South and Central America: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.5.6.1 South and Central America: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.5.6.2 Brazil: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.2.1 Brazil: Transient Protein Expression Market Breakdown, by Product Type
10.5.6.2.2 Brazil: Transient Protein Expression Market Breakdown, by Application
10.5.6.2.3 Brazil: Transient Protein Expression Market Breakdown, by End User
10.5.6.3 Argentina: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.3.1 Argentina: Transient Protein Expression Market Breakdown, by Product Type
10.5.6.3.2 Argentina: Transient Protein Expression Market Breakdown, by Application
10.5.6.3.3 Argentina: Transient Protein Expression Market Breakdown, by End User
10.5.6.4 Rest of South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.4.1 Rest of South and Central America: Transient Protein Expression Market Breakdown, by Product Type
10.5.6.4.2 Rest of South and Central America: Transient Protein Expression Market Breakdown, by Application
10.5.6.4.3 Rest of South and Central America: Transient Protein Expression Market Breakdown, by End User
10.6 Middle East and Africa
10.6.1 Middle East and Africa Transient Protein Expression Market Overview
10.6.2 Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 Middle East and Africa: Transient Protein Expression Market Breakdown, by Product Type
10.6.3.1 Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast Analysis – by Product Type
10.6.4 Middle East and Africa: Transient Protein Expression Market Breakdown, by Application
10.6.4.1 Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast Analysis – by Application
10.6.5 Middle East and Africa: Transient Protein Expression Market Breakdown, by End User
10.6.5.1 Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast Analysis – by End User
10.6.6 Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.6.6.1 Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Saudi Arabia: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.2.1 Saudi Arabia: Transient Protein Expression Market Breakdown, by Product Type
10.6.6.2.2 Saudi Arabia: Transient Protein Expression Market Breakdown, by Application
10.6.6.2.3 Saudi Arabia: Transient Protein Expression Market Breakdown, by End User
10.6.6.3 South Africa: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.3.1 South Africa: Transient Protein Expression Market Breakdown, by Product Type
10.6.6.3.2 South Africa: Transient Protein Expression Market Breakdown, by Application
10.6.6.3.3 South Africa: Transient Protein Expression Market Breakdown, by End User
10.6.6.4 United Arab Emirates: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.4.1 United Arab Emirates: Transient Protein Expression Market Breakdown, by Product Type
10.6.6.4.2 United Arab Emirates: Transient Protein Expression Market Breakdown, by Application
10.6.6.4.3 United Arab Emirates: Transient Protein Expression Market Breakdown, by End User
10.6.6.5 Rest of Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.5.1 Rest of Middle East and Africa: Transient Protein Expression Market Breakdown, by Product Type
10.6.6.5.2 Rest of Middle East and Africa: Transient Protein Expression Market Breakdown, by Application
10.6.6.5.3 Rest of Middle East and Africa: Transient Protein Expression Market Breakdown, by End User
11. Competitive Landscape
11.1 Company Positioning & Concentration
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Transient Protein Expression Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN NV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 GenScript Biotech Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Promega Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Takara Bio Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Agilent Technologies Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Mirus Bio LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bio-Rad Laboratories Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Lonza Group AG
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 MaxCyte Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About the Research Team
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Transient Protein Expression Market Segmentation
Table 2. Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. North America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 7. North America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 8. North America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 9. North America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 10. United States: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 11. United States: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 12. United States: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 13. Canada: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 14. Canada: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. Canada: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. Mexico: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 17. Mexico: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 18. Mexico: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 19. Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 20. Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 22. Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 23. Germany: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 24. Germany: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. Germany: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 26. United Kingdom: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 27. United Kingdom: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 28. United Kingdom: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 29. France: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 30. France: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 31. France: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 32. Italy: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 33. Italy: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 34. Italy: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 35. Spain: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 36. Spain: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 37. Spain: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 38. Rest of Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 39. Rest of Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. Rest of Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 41. Asia Pacific: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 42. Asia Pacific: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 43. Asia Pacific: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 44. Asia Pacific: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 45. China: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 46. China: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 47. China: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 48. Japan: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 49. Japan: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. Japan: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 51. India: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 52. India: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 53. India: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 54. Australia: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 55. Australia: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 56. Australia: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 57. South Korea: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 58. South Korea: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 59. South Korea: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 60. Rest of APAC: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 61. Rest of APAC: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 62. Rest of APAC: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 63. South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 64. South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 65. South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 66. South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 67. Brazil: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 68. Brazil: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 69. Brazil: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 70. Argentina: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 71. Argentina: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 72. Argentina: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 73. Rest of South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 74. Rest of South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 75. Rest of South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 76. Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 77. Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 78. Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 79. Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 80. Saudi Arabia: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 81. Saudi Arabia: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 82. Saudi Arabia: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 83. South Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 84. South Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. South Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 86. United Arab Emirates: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 87. United Arab Emirates: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 88. United Arab Emirates: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 89. Rest of Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 90. Rest of Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 91. Rest of Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 92. Recent Organic Growth Strategies in Transient Protein Expression Market
Table 93. Recent Inorganic Growth Strategies in the Transient Protein Expression Market
Table 94. Glossary of Terms, Transiaent Protein Expression Market
LIST OF FIGURES
Figure 1. Transient Protein Expression Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Transient Protein Expression Market Revenue (US$ Million), 2021-2031
Figure 5. Transient Protein Expression Market Share (%) – by Product Type (2023 and 2031)
Figure 6. Instruments: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Reagents: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Expression Vectors: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Competent Cells: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Transient Protein Expression Market Share (%) – by Application (2023 and 2031)
Figure 11. Genomic Research: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Gene Therapy: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Bio production: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cancer Research: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Drug Development: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Transient Protein Expression Market Share (%) – by End User (2023 and 2031)
Figure 17. Pharmaceutical and Biotechnology Companies: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Academic and Research Institutes: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Clinical Research Organizations: Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Transient Protein Expression Market Breakdown by Region, 2023 and 2031 (%)
Figure 21. North America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 22. North America: Transient Protein Expression Market Breakdown, by Product Type (2023 and 2031)
Figure 23. North America: Transient Protein Expression Market Breakdown, by Application (2023 and 2031)
Figure 24. North America: Transient Protein Expression Market Breakdown, by End User (2023 and 2031)
Figure 25. North America: Transient Protein Expression Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United States: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Canada: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. Mexico: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Europe: Transient Protein Expression Market Breakdown, by Product Type (2023 and 2031)
Figure 31. Europe: Transient Protein Expression Market Breakdown, by Application (2023 and 2031)
Figure 32. Europe: Transient Protein Expression Market Breakdown, by End User (2023 and 2031)
Figure 33. Europe: Transient Protein Expression Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. Germany: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. United Kingdom: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. France: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Italy: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Spain: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Rest of Europe: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Asia Pacific: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Asia Pacific: Transient Protein Expression Market Breakdown, by Product Type (2023 and 2031)
Figure 42. Asia Pacific: Transient Protein Expression Market Breakdown, by Application (2023 and 2031)
Figure 43. Asia Pacific: Transient Protein Expression Market Breakdown, by End User (2023 and 2031)
Figure 44. Asia Pacific: Transient Protein Expression Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 45. China: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Japan: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. India: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. Australia: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. South Korea: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. Rest of APAC: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 52. South and Central America: Transient Protein Expression Market Breakdown, by Product Type (2023 and 2031)
Figure 53. South and Central America: Transient Protein Expression Market Breakdown, by Application (2023 and 2031)
Figure 54. South and Central America: Transient Protein Expression Market Breakdown, by End User (2023 and 2031)
Figure 55. South and Central America: Transient Protein Expression Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 56. Brazil: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Argentina: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Rest of South and Central America: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 60. Middle East and Africa: Transient Protein Expression Market Breakdown, by Product Type (2023 and 2031)
Figure 61. Middle East and Africa: Transient Protein Expression Market Breakdown, by Application (2023 and 2031)
Figure 62. Middle East and Africa: Transient Protein Expression Market Breakdown, by End User (2023 and 2031)
Figure 63. Middle East and Africa: Transient Protein Expression Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 64. Saudi Arabia: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 65. South Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 66. United Arab Emirates: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. Rest of Middle East and Africa: Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 68. Company Positioning & Concentration
Figure 69. Growth Strategies in Transient Protein Expression Market
The List of Companies – Transient Protein Expression Market
o Thermo Fisher Scientific
o Promega Corporation
o Merck KGAA
o Takara Bio Inc
o Qiagen
o Bio-Rad Laboratories, Inc.
o New England Biolabs
o Genscript Biotech Corporation
o Agilent, Lonza
o Mirus Bio LLC
o MaxCyte Inc
o DeRoyal Industries Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.